Shares of Arena Pharmaceuticals rose 2.35% to $65.35 at 10:05 EST on Thursday. The Nasdaq Stock Market is sliding 0.82% to $11801.6, on what seems, at the moment, a positive trend trading session on The Nasdaq Stock Market.
Arena Pharmaceuticals’s last close was $63.85, below its 52-week high of $90.19.
Arena Pharmaceuticals’s sales growth is negative 81.3% for the ongoing quarter and 155.7% for the next. The company’s growth estimates for the current quarter and the next is a negative 8% and a positive 4.5%, respectively.
Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.
Arena Pharmaceuticals’s stock is valued at $65.35 at 10:05 EST, way below its 52-week high of $90.19 and way higher than its 52-week low of $32.95.
Arena Pharmaceuticals’s value is way under its 50-day moving average of $79.04 and below its 200-day moving average of $67.43.